Celltrion, Inc. — Investor Relations & Filings
Celltrion, Inc. is a biopharmaceutical company that provides integrated solutions across the entire value chain, from research and development to clinical trials, regulatory affairs, and large-scale manufacturing. The company specializes in developing and producing innovative therapeutics, including biosimilars and novel biopharmaceuticals. Its portfolio primarily targets autoimmune diseases and oncology. Celltrion is recognized for launching the world's first monoclonal antibody biosimilar. A key product is ZYMFENTRA® (infliximab-dyyb), a subcutaneous formulation for the maintenance treatment of moderately-to-severely active Crohn's disease and ulcerative colitis. The company also develops and manufactures chemical pharmaceuticals.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39057674 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057654 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057640 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057610 | [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057447 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057432 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057423 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057405 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057387 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057358 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057313 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057304 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 39057283 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-04-30 | Korean | ||
| 38996279 | 투자판단관련주요경영사항 (CTP6 SC(허쥬마 피하주사 제형) 유럽 제형 추가 신청) | 2026-04-30 | Korean | ||
| 36123711 | [기재정정]투자판단관련주요경영사항 (CTP51(키트루다 바이오시밀러) 한국 임상 3상 시험계획 변경신청) | 2026-04-24 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Celltrion, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17216/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17216 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17216 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17216 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17216}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celltrion, Inc. (id: 17216)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.